- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Muscarinic Receptor Binding Characteristics in Rat Tissues after Oral Administration of Oxybutynin and Propiverine.
-
- OKI Tomomi
- Department of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka
-
- YAMADA Shizuo
- Department of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka
-
- TOHMA Ayako
- Department of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka
-
- KIMURA Ryohei
- Department of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka
Search this article
Description
Ex vivo muscarinic receptor binding of oxybutynin and propiverine, the most commonly used anticholinergic agents for the treatment in patients with urinary incontinence, was investigated in rat tissues. The oral administration of oxybutynin (50.8 and 127 μmol/kg) caused a significant increase in the apparent dissociation constant (Kd) for specific (−)-[3H]QNB binding in the rat bladder, prostate, submaxillary gland, heart and cerebral cortex, compared with each of the control values. Also, in the submaxillary gland of these rats, there was a reduction in the maximal number of binding sites (Bmax) for (−)-[3H]QNB binding. Similarly, oral administration of propiverine at doses of 74.3-297 μmol/kg brought about a significant increase in the Kd values for (−)-[3H]QNB binding in rat tissues including the bladder, and greater increase in Kd values was seen in the rat prostate, heart and submaxillary gland. On the other hand, oral administration of propiverine, unlike oxybutynin, resulted in very little reduction in the Bmax valules for (−)-[3H]QNB binding in the submaxillary gland. In conclusion, the present study has shown that oxybutynin and propiverine, after oral administration, bind significantly to muscarinic receptors in tissues such as the bladder, which is the target organ for the treatment of urinary incontinence, and that oxybutynin appears to exhibit long-term binding to muscarinic receptors in the salivary gland.
Journal
-
- Biological and Pharmaceutical Bulletin
-
Biological and Pharmaceutical Bulletin 24 (5), 491-495, 2001
The Pharmaceutical Society of Japan
- Tweet
Details 詳細情報について
-
- CRID
- 1390001204626621568
-
- NII Article ID
- 110003638499
-
- NII Book ID
- AA10885497
-
- COI
- 1:CAS:528:DC%2BD3MXjt1alsbc%3D
-
- ISSN
- 13475215
- 09186158
-
- NDL BIB ID
- 5764820
-
- PubMed
- 11379767
-
- Text Lang
- en
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- PubMed
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed